arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ligand Pharmaceuticals Incorporated

LGND Health Care Biotechnology: Pharmaceutical Preparations
$237.00
▲ +0.5% Today
as of Jun 7, 07:19 ET
Last 30 days +2.01% Apr 28 → Jun 05
$205.44 $213.92 $222.39 $230.86 $239.34 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$235.75
High
$240.53
Low
$235.75
Volume
$172,773
Avg Vol
$213,887
Mkt Cap
$4.7B
P/E (TTM)
45.14
Beta
52w High
$247.38
52w Low
$102.50
Div Yield
Shares Out
$20M

Overview

52-week range
$102
$247
93% of range
Avg surprise (last 2)
-923.5%
Avg reaction (last 2)
-6.2%
0% positive
Latest IV / EM
48%
EM ±6.6% · $240 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.88$-0.74$1.40$3.54$5.68 Actual $0.13Actual $-0.59Actual $4.75Actual $-2.88Actual $-0.39Actual $-2.21Est $0.14Actual $0.24Actual $5.68Actual $-0.67Est $0.98 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-52M$-8M$36M$79M$123M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.67 $0.98 -168.4% +69.7% -9.6% earnings
Tue Sep 30, 2025Sep 2025 $5.68 financials
Mon Jun 30, 2025Jun 2025 $0.24 financials
Thu May 8, 2025Mar/2025 $-2.21 $0.14 -1,679% -2.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.39 financials
Sun Jun 30, 2024Jun 2024 $-2.88 financials
Sun Mar 31, 2024Mar 2024 $4.75 financials
Sat Sep 30, 2023Sep 2023 $-0.59 financials
Fri Jun 30, 2023Jun 2023 $0.13 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$17M$55M$8M$-36M$3M$-19M
Net income$-13M$117M$5M$-42M$-7M$-52M
EPS (diluted)$-0.67$5.68$0.24$-2.21$-0.39$-2.88

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$115M$175M$139M$68M$48M$72M$64M$18M
Inventory$13M$9M$12M$15M$15M$14M$17M$19M
Total current assets$865M$832M$754M$353M$309M$332M$309M$312M
Total assets$1.53B$1.56B$1.48B$949M$905M$942M$955M$866M
Long-term debt
Total liabilities$535M$543M$527M$120M$110M$111M$114M$91M
Total equity$997M$1.02B$950M$827M$796M$830M$841M$775M

Implied volatility — last 90 days

42%45%47%50%52% Jun 07 — IV 48% · EM ±6.6%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.